Holen Sie sich die Stockscreener-App
2.60
2.26%
-0.06
Handel nachbörslich:
2.64
0.04
+1.54%
Schlusskurs vom Vortag:
$2.66
Offen:
$2.66
24-Stunden-Volumen:
455.19K
Relative Volume:
0.73
Marktkapitalisierung:
$155.69M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-40.33M
KGV:
-1.4525
EPS:
-1.79
Netto-Cashflow:
$-39.53M
1W Leistung:
-24.42%
1M Leistung:
-23.98%
6M Leistung:
-42.09%
1J Leistung:
-4.41%
1-Tages-Spanne:
$2.56
$2.665
1-Wochen-Bereich:
$2.41
$2.815
52-Wochen-Spanne:
$2.375
$5.54
Eledon Pharmaceuticals Inc Stock (ELDN) Company Profile
Firmenname
Eledon Pharmaceuticals Inc
Sektor
Branche
Telefon
949-238-8090
Adresse
19800 MACARTHUR BLVD., IRVINE
Vergleichen Sie ELDN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELDN
Eledon Pharmaceuticals Inc
|
2.60 | 159.29M | 0 | -40.33M | -39.53M | -1.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Eledon Pharmaceuticals Inc Stock (ELDN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-01-28 | Eingeleitet | Guggenheim | Buy |
| 2022-05-13 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-03-23 | Eingeleitet | Cantor Fitzgerald | Overweight |
Eledon Pharmaceuticals Inc Aktie (ELDN) Neueste Nachrichten
Published on: 2025-08-13 08:17:22 - Newser
Real time alert setup for Eledon Pharmaceuticals Inc. performance2025 Trading Recap & Daily Stock Trend Reports - Newser
Can Eledon Pharmaceuticals Inc. rally from current levelsDividend Hike & AI Forecast for Swing Trade Picks - Newser
Can Eledon Pharmaceuticals Inc. hit a new high this monthJuly 2025 Institutional & Low Risk Entry Point Tips - Newser
Statistical indicators supporting Eledon Pharmaceuticals Inc.’s strengthQuarterly Trade Review & Risk Controlled Daily Plans - Newser
Eledon Pharmaceuticals Inc. stock outlook for YEARTrade Risk Report & Expert Approved Momentum Trade Ideas - Newser
Why Eledon Pharmaceuticals Inc. is moving today [Trade Exit Summary]Free High Accuracy Swing Trade Signals - Newser
Custom watchlist performance reports with Eledon Pharmaceuticals Inc.Price Movement and Market Sentiment Analysis - Newser
Can trapped investors hope for a rebound in Eledon Pharmaceuticals Inc.2025 Volatility Report & Community Shared Stock Ideas - Newser
How to recover losses in Eledon Pharmaceuticals Inc. stockFree Trend Following Strategy With Stop Loss - Newser
Combining price and volume data for Eledon Pharmaceuticals Inc.Downside Control Plan With Support Analysis - Newser
How Eledon Pharmaceuticals Inc. stock performs during market volatilityFree Multi-Bagger Potential Stock Forecast Tools - Newser
Detecting support and resistance levels for Eledon Pharmaceuticals Inc.Free Oversold Bounce Stock Play Ideas - Newser
Why Eledon Pharmaceuticals Inc. is moving todayLow-Risk Reversal Pattern Analysis Tracker - Newser
Published on: 2025-08-10 22:59:19 - Newser
The week in pharma: action, reaction and insight – week to August 8 - The Pharma Letter
Using Bollinger Bands to evaluate Eledon Pharmaceuticals Inc.Bear Market Safe Zone Technical Analysis - Newser
Has Eledon Pharmaceuticals Inc. Stock Ever Crashed Historical Volatility ReviewFree Trade Timing Strategy With Technical Data - Newser
Is Eledon Pharmaceuticals Inc. stock a good hedge against inflationTrade Plan With Low Risk High Return - Newser
Volatility clustering patterns for Eledon Pharmaceuticals Inc.Free High Return Stock Focus With Safety - Newser
Should you hold or exit Eledon Pharmaceuticals Inc. nowFree Access to Real-Time Trade Insights - Newser
Using portfolio simulators with Eledon Pharmaceuticals Inc. includedEarly Entry Ideas with Momentum Potential - Newser
Order flow analysis tools used on Eledon Pharmaceuticals Inc.Watchlist Generator With Real-Time Entry - Newser
Eledon Pharmaceuticals Inc. Company Revenue and Profit Trends: A Deep DiveWeekly Chart-Based Forecast for Traders - Newser
What makes Eledon Pharmaceuticals Inc. stock price move sharplyWatchlist Generator for Smart Money Signals - Newser
Ipsen is no longer advancing Sutro’s ADC; Layoffs at Tune Therapeutics - Endpoints News
Eledon Pharmaceuticals shares rise 2.37% after-hours following updated Phase Ib data conference call. - AInvest
Mixed market reaction to Eledon Phase Ib trial for tegoprubart - The Pharma Letter
Eledon Plunges 17.15% on Clinical Trial Data, Oracle Rumors - AInvest
Promising Phase 1b Results of Tegoprubart Support Buy Rating for Eledon Pharmaceuticals - TipRanks
Eledon Pharmaceuticals shares fall 9.88% premarket despite positive Phase 1b trial data for tegoprubart. - AInvest
Eledon Pharmaceuticals Reports Promising Phase 1b Trial Results - TipRanks
Finanzdaten der Eledon Pharmaceuticals Inc-Aktie (ELDN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):